VIP (6-28) (human, rat, porcine, bovine)
Cat. No. 1905
Alternative Name: Vasoactive Intestinal Peptide (6-28)
Biological ActivityVIP receptor antagonist.
(Modifications: Asn-23 = C-terminal amide)
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Marko (2002) An evaluation of the efficacy of vasoactive intestinal polypeptide antagonists in vivo in the anaesthetized dog. Pharmacology 66 206. PMID: 12393943.
Mohney and Zigmond (1998) Vasoactive intestinal peptide enhances its own expression in sympathetic neurons after injury. J.Neurosci. 18 5285. PMID: 9651211.
Fishbein et al (1994) A chimeric VIP-PACAP analogue but not VIP pseudopeptides function as VIP receptor antagonists. Peptides 15 95. PMID: 7912431.
If you know of a relevant reference for VIP (6-28) (human, rat, porcine, bovine) please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses VIP (6-28) (human, rat, porcine, bovine) from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: VIP (6-28) (human, rat, porcine, bovine), supplier, VIP, antagonists, Vasoactive, Intestinal, Peptide, Receptors, VPAC, Tocris Bioscience, VIP Receptor Antagonist products
Find multiple products by catalog number
New Products in this Area
Reverse analog of BradykininTASP 0390325
Potent and selective V1B receptor antagonist; orally bioavailableML 233
Non-peptide apelin receptor agonistBML 111
FPR2 (lipoxin A4 receptor) agonistAmylin (rat)
Potent endogenous peptide agonist for amylin, calcitonin, CGRP and adrenomedullin receptorsCalcitonin (human)
Endogenous calcitonin receptor agonist; inhibits bone resorptionSpexin
Potent GAL2/3 agonist; exhibits anxiolytic effects in vivoMM 54
Potent apelin receptor antagonist
April 22 - 26, 2017
Chicago, IL, USA